C reactive protein level in pulmonary embolism. A marker of inflammatory processes in chronic thromboembolic pulmonary hypertension?

P. Piszko, J. Lewczuk, L. Lenartowska, A. Kaczmarzyk, B. Szafran, J. Kowal, M. Mazij, A. Konieczny (Wroclaw, Poland)

Source: Annual Congress 2007 - Venous thromboembolic disease
Session: Venous thromboembolic disease
Session type: Thematic Poster Session
Number: 3550
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
P. Piszko, J. Lewczuk, L. Lenartowska, A. Kaczmarzyk, B. Szafran, J. Kowal, M. Mazij, A. Konieczny (Wroclaw, Poland). C reactive protein level in pulmonary embolism. A marker of inflammatory processes in chronic thromboembolic pulmonary hypertension?. Eur Respir J 2007; 30: Suppl. 51, 3550

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Inflammatory cell accumulation in pulmonary arteries is associated with systemic inflammation in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease
Year: 2010


Involvement of the pulmonary micro-vasculature in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


ERS statement on chronic thromboembolic pulmonary hypertension
Source: ERS webinar 2021: ERS statement on chronic thromboembolic pulmonary hypertension
Year: 2021


A 1-year evolution of pulmonary artery pressure in the patients treated with various therapeutic methods after acute pulmonary embolism (PE). Its impact on the chronic thromboembolic pulmonary hypertension (CTEPH) development
Source: Eur Respir J 2003; 22: Suppl. 45, 221s
Year: 2003

Is inflammation a potential therapeutic target in chronic thromboembolic pulmonary hypertension?
Source: Eur Respir J 2014; 44: 842-845
Year: 2014


Microvascular disease in chronic thromboembolic pulmonary hypertension: a role for pulmonary veins and systemic vasculature
Source: Eur Respir J 2014; 44: 1275-1288
Year: 2014



Are we screening survivors of acute pulmonary embolism (PE) for chronic thromboembolic pulmonary hypertension (CTEPH)?
Source: Annual Congress 2011 - Clinical features of pulmonary thromboembolism
Year: 2011

Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat
Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017
Year: 2017



C-reactive protein and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease with pulmonary arterial hypertension
Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD
Year: 2010

Pulmonary embolism and the consequences for the right heart
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136
Year: 2006

The ADAMTS13–VWF axis is dysregulated in chronic thromboembolic pulmonary hypertension
Source: Eur Respir J, 53 (3) 1801805; 10.1183/13993003.01805-2018
Year: 2019



Differential expression of plasma microRNAs in chronic thromboembolic pulmonary hypertension and pulmonary embolism related to occult cancer
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


Chronic thromboembolic pulmonary hypertension after acute pulmonary embolism: to screen or not to screen?
Source: Eur Respir J, 51 (4) 1800440; 10.1183/13993003.00440-2018
Year: 2018



Prevalence of chronic thromboembolic pulmonary hypertension (CTEPH) in patients after pulmonary embolism
Source: International Congress 2018 – Clinical aspects of pulmonary hypertension
Year: 2018

Frequency of chronic thromboembolic pulmonary hypertension screening after pulmonary embolism in cancer patients.
Source: International Congress 2018 – Pulmonary embolism: long-term sequelae and advances in therapies
Year: 2018



Novel hypoxia system to assess endothelial dysfunction in chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Virtual Congress 2021 – Pathogenesis and pathophysiology of pulmonary hypertension
Year: 2021


How does inflammation contribute to pulmonary hypertension?
Source: Eur Respir J, 51 (1) 1702403; 10.1183/13993003.02403-2017
Year: 2018



Regulation of inflammation process in chronic thromboembolic pulmonary hypertension: a potential role of platelet-activating factor-acetylhydrolase
Source: Annual Congress 2006 - Pulmonary circulation: inflammation and remodelling
Year: 2006